Pharming Group to participate in Fireside Chat at Jefferies Global Healthcare Conference in London

Rhea-AI Summary

Pharming Group (Euronext: PHARM / Nasdaq: PHAR) announced management will participate in the Jefferies Global Healthcare Conference in London on November 17-20, 2025. Fabrice Chouraqui, Chief Executive Officer, will take part in a Fireside Chat Q&A on Wednesday, November 19 at 10:00 GMT / 11:00 CET. A live webcast and replay will be available via the company website under Upcoming Events and News. Investors seeking one-to-one meetings or more details can contact Investor Relations at investor@pharming.com or coordinate through a Jefferies representative.

Leiden, the Netherlands, October 30, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming management will participate in the Jefferies Global Healthcare Conference in London, UK, on November 17-20, 2025.

Fabrice Chouraqui, Chief Executive Officer, will participate in a Fireside Chat Q&A session on Wednesday, November 19 at 10:00 GMT/11:00 CET. A live webcast and replay of the presentation can be found in the “Upcoming Events” and “News” sections of Pharming’s website.

For more information about the conference, or to schedule a one-to-one meeting with Pharming’s management team, please contact Investor Relations at investor@pharming.com or your Jefferies representative.

About Pharming Group N.V.
Pharming Group N.V. (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. We are developing and commercializing a portfolio of innovative medicines, including small molecules and biologics. Pharming is headquartered in Leiden, the Netherlands, with a significant proportion of its employees based in the U.S.

For more information, visit www.pharming.com and find us on LinkedIn.

For further public information, contact:
Investor Relations
Michael Levitan, VP Investor Relations & Corporate Communications
T: +1 (908) 705 1696
E: investor@pharming.com

Media Relations
Global: Saskia Mehring, Corporate Communications Manager
T: +31 6 28 32 60 41
E: media.relations@pharming.com

U.S.: Ethan Metelenis (Precision AQ on behalf of Pharming)
T: +1 (917) 882-9038

Netherlands: Leon Melens (LifeSpring Life Sciences Communication on behalf of Pharming)
T: +31 6 53 81 64 27

Attachment

• Pharming Fireside Chat at Jefferies Global Healthcare Conference in London_EN_30OCT25

FAQ

When will Pharming (PHARM / PHAR) present at the Jefferies Global Healthcare Conference in London?

Pharming management will attend the conference on November 17-20, 2025, with the CEO Fireside Chat on November 19, 2025 at 10:00 GMT / 11:00 CET.

How can investors watch Pharming's (PHARM) Fireside Chat on November 19, 2025?

A live webcast and replay of the Fireside Chat will be available in the company website's Upcoming Events and News sections.

Who will represent Pharming (PHARM) at the Jefferies conference in London?

Fabrice Chouraqui, Chief Executive Officer, will participate in the Fireside Chat Q&A on November 19, 2025.

How do I request a one-to-one meeting with Pharming management at the Jefferies conference?

Contact Pharming Investor Relations at investor@pharming.com or arrange a meeting through your Jefferies representative.

Where on Pharming's website is the conference webcast posted after the event?

The live webcast and replay will be posted in the Upcoming Events and News sections of the company's website.

What time is Pharming's (PHARM) CEO Fireside Chat in local London time on November 19, 2025?

The session is at 10:00 GMT, which corresponds to 11:00 CET; local London time is 10:00 GMT on November 19, 2025.